Poland· PL-100099248

Flixotide

A fluticasone product containing fluticasoni propionas, registered in Poland by GlaxoSmithKline Trading Services Limited. The same ATC class is registered in 16 of our 19 countries.

ATC R03BA05

Checked against URPL (Poland) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about fluticasoni propionasAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Fluticasone is registered in 16 of 19 countries.

Countries holding a registration under ATC R03BA05 (fluticasone), each read from that country’s own register.

This record: Poland, from URPL (Poland)
9 of them publish a price we can compare per daily dose

Search fluticasone products by name

Fluticasone · ATC R03BA05

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Germany
Icelandprice
Ireland
Italyprice
Japan
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)

Active substance: Fluticasoni propionas
Manufacturer: GlaxoSmithKline Trading Services Limited
Country: Poland (PL)
ATC code: R03BA05
ATC class: Fluticasone
Defined daily dose: 0.6 mg, Inhal
Reimbursed: Not published by this register
Source register: URPL (Poland)
Last checked: September 27, 2026

Packs & prices · 2

2 priced

gtin
05909990851515
60 daw.
PLN 59.74
gtin
05909990851522
120 daw.
PLN 94.25

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

576 interactions on record for fluticasone.

Graded by severity as the source publishes them — 35 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check fluticasone against other medicines How interaction checks work

Fluticasone · interactions on record

576 records

35 severe
44 moderate
20 minor
475 info

Most severe, free to view

LonafarnibA16AX20severe
ConivaptanC03XA02severe
MifepristoneG03XB01severe
DesmopressinH01BA02severe

2 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Fluticasone in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fluticasone products

Authorised across Europe · EMA

The same active substance is authorised in 30 EEA countries. Names it is sold under:

Austria · Flixonase Aquosum, Flixotide Diskus Forte
Belgium · Flixonase Aqua, Flixotide
Bulgaria · Аркуист, Фликсоназе
Cyprus · Cutivate, Flixonase Aqueous
Czechia · Flixotide Diskus, Flixotide Inhaler N
Germany · Flutica, Fluticason Cipla
Denmark · Flixotide, Flurhin
Estonia · Cutivate Cream, Flixonase
Spain · Avancort, Flixonase
Finland · Flixonase, Flixotide Diskus
France · Fixorinox, Flixonase
United Kingdom (Northern Ireland) · Aeronate, Boots Allergy Relief
Greece · Alerxem, Bocacort-S
Croatia · Flixonase, Flixotide Inhaler
Hungary · Cutivate, Flixonase
Ireland · Arquist, Flixonase Allergy Relief
Iceland · Avamys, Flixotide
Italy · Aktanos, Deflut
Liechtenstein · Avamys
Lithuania · Cutivate, Flixotide
Luxembourg · Flixonase Aqua, Flixotide
Latvia · Flixonase, Flixotide
Malta · Cutivate, Flihaler
Netherlands · Cortifil, Cutivate
Norway · Avamys, Flurhin
Portugal · Brisovent Diskus, Brisovent Inalador
Romania · Arquist, Cutivate
Sweden · Arquist, Fluticasone Cipla
Slovenia · Flixonase, Flixotide
Slovakia · Flixonase Aqueous, Flixotide Diskus

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/607766ff-837f-4e57-8b73-a2b4ecdae7f1
GET /v1/drugs/607766ff-837f-4e57-8b73-a2b4ecdae7f1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Aerozol inhalacyjny, zawiesina",
  "source": "urpl",
  "strength": "250 mcg/dawkę inh.",
  "packaging": "05909990851515 ¦ Rp ¦ 17004\n1 poj. 60 dawek\n05909990851522 ¦ Rp ¦ 17005\n1 poj. 120 dawek",
  "substance": "Fluticasoni propionas 250 mcg/ dawkę inhalacyjną (mikronizowany)",
  "common_name": "Fluticasoni propionas",
  "pl_product_id": "100099248",
  "pozwolenie_nr": "08515",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

API reference MCP server Plans

See everything about fluticasone.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console